Using biochemical assays, we demonstrated that DIMATE efficiently suppresses ALDH1 and ALDH3 enzymatic activities in an expanded panel of 26 NSCLC cell lines that included the 14 NSCLC cell line panel and 12 primary cell lines from patient-derived xenografts (Fig. 2b). Here, ALDH1A1 is linked to non-small cell lung carcinoma.